1985
DOI: 10.1016/s0140-6736(85)90169-2
|View full text |Cite
|
Sign up to set email alerts
|

Systemic Complications of Intravesical BCG Therapy for Bladder Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
13
0
1

Year Published

1986
1986
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(14 citation statements)
references
References 6 publications
0
13
0
1
Order By: Relevance
“…Under certain conditions, dormant mycobacteria are reactivated and frequently disseminate to extrapulmonary organ systems, thereby establishing a severe clinical complication of pulmonary tuberculosis (8,(11)(12)(13). Notably, not only M. tuberculosis but also M. bovis BCG may cause mycobacterial dissemination in humans, as has been noted, e.g., in patients treated by intravesical M. bovis BCG therapy for bladder cancer, which may lead to systemic BCGitis, a severe systemic BCG infection (14). Therefore, elucidation of the molecular pathways underlying the control of systemic M. bovis BCG infection may also inform about the regulatory pathways controlling M. tuberculosis dissemination.…”
mentioning
confidence: 96%
“…Under certain conditions, dormant mycobacteria are reactivated and frequently disseminate to extrapulmonary organ systems, thereby establishing a severe clinical complication of pulmonary tuberculosis (8,(11)(12)(13). Notably, not only M. tuberculosis but also M. bovis BCG may cause mycobacterial dissemination in humans, as has been noted, e.g., in patients treated by intravesical M. bovis BCG therapy for bladder cancer, which may lead to systemic BCGitis, a severe systemic BCG infection (14). Therefore, elucidation of the molecular pathways underlying the control of systemic M. bovis BCG infection may also inform about the regulatory pathways controlling M. tuberculosis dissemination.…”
mentioning
confidence: 96%
“…Systemic serious complications may not be apparent until several weeks after BCG administration. They in clude disseminated BCG infection in distant organs [8][9][10][11] (granulomatous hepatitis, prostatitis, renal abscess, retroperitoneal lymphadenopathy and miliary pulmonary disease) or systemic hypersensitivity reactions [12] (pan cytopenia, fever, hepatitis, pneumonitis, renal insuffi ciency). Ten fatal cases have been reported with sepsis or anaphylaxis related to intravesical use [13].…”
Section: Discussionmentioning
confidence: 99%
“…Among these, there were 2 deaths [42][43][44][45]. [36][37][38][39] All 6 patients met the criteria for systemic inflammatory immune response during the course of their illness. Common features include fever, hepatosplenomegaly, transaminitis, and elevated inflammatory markers.…”
Section: Hepatic Complicationsmentioning
confidence: 99%
“…At the tissue level, granulomatous nephritis, interstitial nephritis, and glomerulonephritis with immune deposits have been documented. [38][39][40][41][42][43][44][45][46] Patients may fit nephritic or nephrotic clinical criteria. Granulomatous nephritis may cause severe renal compromise; one case led to nephroureterectomy.…”
Section: Renal Complicationsmentioning
confidence: 99%